Clinical Trials Logo

Clinical Trial Summary

Study Objectives The current definitive treatment options for urethral stricture disease include endoscopic urethrotomy known as Direct Vision Internal Urethrotomy (DVIU) or open reconstruction known as urethroplasty (1-6). The purpose of this study is to determine feasibility of endoscopic-only repair of urethral stricture or bladder neck contracture using a combination of existing surgical techniques of internal urethrotomy (or bladder neck incision) augmented by buccal mucosal graft.


Clinical Trial Description

Background and Rationale There are two definitive treatment options for urethral strictures: DVIU and open urethroplasty. DVIU is an endoscopic procedure considered to be minimally invasive, but also with a high failure rate of 60-92%. The repeated DVIUs are reported to have even higher failure rates. On the other hand, open urethroplasty, considered a gold standard for reconstruction, is invasive, requires incision of the perineum or urethra, leaves a life-long scar, and has long term success rates of 74-95%. The details of DVIU and open urethroplasty are discussed below.

DVIU involves passing a cystoscope into the urethra to the level of stricture and incising the stricture longitudinally to create a wide passage to the level of normal urethra on the proximal side. The hope is to cut through the scar to the level of healthy underlying tissue and in the process of healing to populate the cut surface with healthy urethral epithelium (or at least to stabilize the scar in open configuration). In most cases, the scarring recurs faster than epithelization and most strictures recur after DVIU within 7-8 months. Studies show the strictures after traditional repeat DVIU are longer and require more involved reconstruction than strictures in patients without prior instrumentation.

Open urethroplasty for urethral strictures or bladder neck contractures usually involves longitudinal incision of the urethra (from outside in) and augmentation of the incised part with a strip of harvested Buccal Mucosal Graft (BMG). The goal of the operation is to create a wide urethral lumen for the patient to be able to pass urine without obstruction.

The first step of the procedure for DVIU and open reconstruction are nearly the same: a longitudinal incision of the scarred portion of the urethra. The difference is in the second part: covering the defect with buccal mucosal graft as in open urethroplasty vs leaving the incision uncovered and exposed to passage of urine.

Investigators of this study hereby propose to combine the minimally invasive technique of the DVIU with the technique of augmenting the incised stricture (or bladder neck contracture) using buccal mucosal graft placed endoscopically by means of application of liquid suspended graft. A similar, but more invasive technique was reported by Seith et al in 2012 performed in 12 patients with the exception of need for small open perineal incision for graft fixation. A purely endoscopic skin graft placement into urethra was reported by Naude in 1998 in 53 patients with 95% success rate at 2 years follow up. While he has not made actual incisions, his approach required percutaneous perineal needle placement for graft delivery and a specialized device for graft delivery and graft fixation. The procedure proposed for current trial is purely endoscopic with buccal graft placement and fixation augmented by fibrin glue. This type of fibrin glue sealant is readily available and widely used in General Surgery, Plastic Surgery and in Urology specifically for urethral reconstruction). This will allow for significantly less invasive procedure, shorter procedure time, absence of traditional perineal incision or needle puncture, and earlier return home (same day vs 1-3 days), earlier catheter removal (5-7 days vs 21 days) and earlier return to regular activities (1 week vs 6 weeks).

Overall, the aim is to improve the outcomes of traditional endoscopic procedure while eliminating morbidity of the open reconstruction with added benefits of earlier convalescence and health care savings from decreased surgical morbidity and shortened hospital stay. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03061344
Study type Interventional
Source State University of New York - Upstate Medical University
Contact Dmitriy Nikolavsky, MD
Phone 315-464-1500
Email nikolavd@upstate.edu
Status Not yet recruiting
Phase Phase 1
Start date February 2017
Completion date October 2021

See also
  Status Clinical Trial Phase
Completed NCT03572348 - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. N/A
Completed NCT02321670 - Scandinavian Urethroplasty Study N/A
Recruiting NCT05519566 - The Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture N/A
Recruiting NCT04071925 - 9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
Terminated NCT02551783 - Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft N/A
Active, not recruiting NCT03270384 - Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Not yet recruiting NCT03258658 - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Phase 1
Completed NCT03973619 - Urethral Stricture: A Comparison Between Jugal or Labial Graft Urethroplasty N/A
Recruiting NCT04965025 - Multi-stage Urethroplasty With Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage N/A
Withdrawn NCT03851952 - Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study N/A
Recruiting NCT04161365 - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Urethral Strictures N/A
Completed NCT02948842 - Clostridium Histolyticum Collagenase Injection for Urethral Disease Phase 2
Not yet recruiting NCT06384066 - Mobile Health Application to Improve Patient Satisfaction After Urethroplasty N/A
Completed NCT03859024 - Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty Phase 4
Active, not recruiting NCT03499964 - ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease N/A
Terminated NCT02634619 - A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty N/A
Not yet recruiting NCT00918528 - Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy Phase 1/Phase 2
Not yet recruiting NCT06064968 - Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture N/A
Completed NCT05078788 - Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture N/A
Enrolling by invitation NCT03205670 - Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers Early Phase 1